TrimRx's Blog
Wegovy Brain Health — Cognitive Effects & Neural Safety
Wegovy (semaglutide) affects multiple brain regions beyond appetite control. Research shows both cognitive improvements and risks worth understanding.
Wegovy Addiction Recovery — Separating Myth from Reality
Wegovy is not physically addictive, but psychological dependence on weight management medication differs from substance addiction. Here’s what recovery
Wegovy Alzheimers — GLP-1 Link Research | TrimrX Blog
Research shows GLP-1 agonists like Wegovy may reduce Alzheimer’s risk by up to 54% through anti-inflammatory pathways—here’s what the clinical evidence
Wegovy Alcohol Use Disorder — Does It Reduce Drinking?
Wegovy (semaglutide) shows emerging evidence of reducing alcohol intake in some patients through GLP-1 receptor pathways affecting reward signaling.
Wegovy Gambling Addiction — The Compulsive Behavior Link
Wegovy doesn’t cause gambling addiction through direct neurochemical action, but GLP-1 receptor changes can unmask compulsive behaviors in predisposed
Wegovy Smoking Cessation — Does It Help You Quit Smoking?
Wegovy doesn’t treat nicotine dependence — it targets GLP-1 receptors for weight loss, not addiction pathways. Here’s what the research shows.
Wegovy Compulsive Shopping — The Impulse Control Link
Wegovy may trigger compulsive shopping in some patients through dopamine pathway changes. We explain the mechanism, warning signs, and what to do if it
Wegovy Social Anxiety — Does GLP-1 Therapy Help or Hurt?
Wegovy doesn’t directly treat social anxiety, but weight loss can improve confidence. Here’s what clinical evidence shows about GLP-1 medications and
Mounjaro Plateau 3 Months — Why Weight Loss Stalls & How to
Weight loss plateaus after three months on Mounjaro happen when metabolic adaptation outpaces GLP-1 signalling. Here’s what to adjust — and when to
